Techniques innovantes pour optimiser la balance bénéfice/risque dans le contexte de la ré-irradiation (notice n° 1054975)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02765cam a2200325 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250128130505.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Beddok, Arnaud |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Techniques innovantes pour optimiser la balance bénéfice/risque dans le contexte de la ré-irradiation |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2025.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 100 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The re-irradiation (reRT) of cancers poses a major challenge due to the increased risks of toxicity in patients who have had previous radiotherapy. This article explores technological advancements in radiotherapy to optimise reRT. Proton therapy is a favoured approach for head and neck cancers, making it possible to reduce irradiated volumes and minimising toxicity through its specific dose distribution. For prostate cancers, stereotactic body radiotherapy (SBRT) offers an effective alternative with precise tumour control and lower toxicity. Finally, FLASH radiotherapy shows promising potential to reduce pulmonary toxicity, particularly in the context of reRT. These innovations provide encouraging perspectives to improve the benefit/risk balance in the treatment of recurrences. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | La ré-irradiation (reRT) des cancers représente un défi majeur en raison des risques accrus de toxicité pour les patients déjà irradiés. Cet article explore les avancées technologiques en radiothérapie pour optimiser la reRT. La protonthérapie est une approche privilégiée pour les cancers ORL, permettant de réduire les volumes irradiés et de minimiser la toxicité grâce à sa distribution spécifique de dose. Pour les cancers de la prostate, la radiothérapie stéréotaxique (SBRT) est une alternative efficace avec un contrôle tumoral précis et une toxicité moindre. Enfin, la radiothérapie FLASH montre un potentiel prometteur pour réduire la toxicité pulmonaire, en particulier dans le contexte de reRT. Ces innovations offrent des perspectives encourageantes pour améliorer la balance bénéfice/risque dans le traitement des récidives. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | radiothérapie stéréotaxique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | protonthérapie |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | toxicité pulmonaire |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | radiothérapie FLASH |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | ré-irradiation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | re-irradiation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | FLASH radiotherapy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | pulmonary toxicity |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | stereotactic body radiotherapy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | proton therapy |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fouillade, Charles |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pasquier, David |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Thariat, Juliette |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Innovations & Thérapeutiques en Oncologie | Volume 10 | 6 | 2025-01-23 | p. 398-400 | 2431-3203 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-innovations-et-therapeutiques-en-oncologie-2024-6-page-398?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-innovations-et-therapeutiques-en-oncologie-2024-6-page-398?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux